Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • NovaBay Pharmaceuticals (NBY) Expands Partnership Agreement With China Pioneer Pharma 0 comments
    Dec 3, 2013 2:41 PM | about stocks: NBY

    Clinical-stage biopharmaceutical company NovaBay Pharmaceuticals announced it has expanded its NeutraPhase commercial partnership agreement with Shanghai-based China Pioneer Pharma Holdings Limited. The new agreement replaces the former option to invest $3 million in NovaBay, and the expanded agreement includes licensing rights to two new products: CelleRx and i-Lid Cleanser, both developed by the MediBay Business Unit of NovaBay. The expanded partnership agreement covers commercialization and distribution of these products in China and 11 countries in Southeast Asia.

    A new product developed by NovaBay, CelleRx was created for use in the aesthetic dermatology field. i-Lid Cleanser, the company's other new product, was designed for use in ophthalmological applications. In conjunction with the expansion of the commercial partnership agreement to include these two NeutroPhase products, Pioneer has agreed to buy 5 million unregistered shares of NovaBay stock for a total investment of $5.7 million.

    "We have been extremely pleased with our relationship with NovaBay and look forward to the upcoming approval of NeutroPhase in China," said Pioneer Chairman and CEO Paul Li. "We believe this market expansion will open up additional market opportunities. We are delighted to increase our equity investment in NovaBay and believe its portfolio of products has a great deal of promise globally."

    Going forward, NovaBay plans to establish additional marketing partnerships for CelleRx and i-Lid Cleaner in select territories around the world. Those interested in partnering opportunities in the United States, Europe and elsewhere in the world should contact Senior VP, Business Development Roy Wu at this link: novabay.com/contact-business-development.

    For more information, visit novabay.com or pioneer-pharma.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: NBY
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.